FCR vs. BR - Is One Better?
26 ago 2016 ·
4 min. 22 sec.
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
Jennifer Brown, MD, discusses the choice in chemoimmunotherapy, FCR (fludarabine, cyclophosphamide and rituximab) vs BR. FCR has been the standard therapy for previously untreated fit patients with CLL under about...
mostra di più
Jennifer Brown, MD, discusses the choice in chemoimmunotherapy, FCR (fludarabine, cyclophosphamide and rituximab) vs BR. FCR has been the standard therapy for previously untreated fit patients with CLL under about the age of 70. While BR (bendamustine and rituximab), is a relatively newer therapy, which had been studied in a couple of phase two trials - smaller single arm trials and look to be promising.
mostra meno
Informazioni
| Autore | cancerGRACE |
| Organizzazione | Global Resource for Advancing Cancer Education |
| Sito | - |
| Tag |
Copyright 2026 - Spreaker Inc. an iHeartMedia Company
Commenti